Aulos Bioscience

Cambridge, United States

Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.

$20.0M raised

Aug 2023

Series A

Biotechnology Health Care Life Science Medical Oncology

Top Investors

Apple Tree Partners

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Aulos Bioscience

How much funding has Aulos Bioscience raised?

Aulos Bioscience has raised $20.0M in total funding. The most recent round was Series A. The last funding was announced in August 2023.

Who are Aulos Bioscience's investors?

Aulos Bioscience's investors include Apple Tree Partners.

Where is Aulos Bioscience headquartered?

Aulos Bioscience is headquartered in Cambridge, United States.

What does Aulos Bioscience do?

Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.

What stage is Aulos Bioscience at?

Aulos Bioscience is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 1, 2023.

MLA

"Aulos Bioscience — Funding & Investors." VCBacked, August 1, 2023, https://www.vcbacked.co/company/aulos-bioscience. Accessed June 4, 2026.

APA

VCBacked. (2023). Aulos Bioscience — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/aulos-bioscience

Wikipedia (cite web)

{{cite web |title=Aulos Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/aulos-bioscience |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 1, 2023.

Similar Companies in Biotechnology